Is autoimmunity the Achilles' heel of cancer immunotherapy?

June, Carl H, Warshauer, Jeremy T, Bluestone, Jeffrey A·2017·Nature Medicine
DOI 10.1038/nm.4321

Cited by (445)

Items 401–445 of 445

  1. Combining a nanoparticle-mediated radioimmunotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
    Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum B. Barsoumian, Kewen He, Duygu Sezen, Dawei Chen, Mark D. Wasley, Jordan DA SILVA, Joylise Mitchell et al. · 2022 · Research Square
  2. Immune Response and Its Role in Cancer
    Anubhab Mukherjee, Vijay Sagar Madamsetty, Sudip Mukherjee · 2021 · Synthesis lectures on biomedical engineering
  3. Clinical Applications of Novel Delivery Routes of Immunotherapy Drugs and Vaccines
    Simin Seyedpour, Nima Rezaei · 2023 · Springer eBooks
  4. Data from Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors
    Maria Grigoriou, Aggelos Banos, Aikaterini Hatzioannou, Andreas Kloetgen, Panagiotis Kouzis, Despoina Aggouraki, Roubini Zakopoulou, Giorgos Bamias, Eva N. Kassi, Dimitriοs Mavroudis et al. · 2023
  5. Data from Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors
    Maria Grigoriou, Aggelos Banos, Aikaterini Hatzioannou, Andreas Kloetgen, Panagiotis Kouzis, Despoina Aggouraki, Roubini Zakopoulou, Giorgos Bamias, Eva N. Kassi, Dimitriοs Mavroudis et al. · 2023
  6. Colon Cancer, Angiogenesis and Therapy
    Bou Hamdan M · 2021 · Annals of Reviews & Research
  7. Introduction to Phase I Dose-Finding Clinical Trials
    Haitao Pan, Ying Yuan · 2023 · Springer eBooks
  8. Notfälle in der Medikamentösen Tumortherapie
    Analena Elisa Handke, Thomas Hilser, Martin Bögemann, Katrin Schlack, Viktor Grünwald · 2023 · Aktuelle Urologie
  9. Rheumatological manifestations in patients with malignancies: Relation to immune modulation therapy
    Nouran M. El-Shahat, Howaida E. Mansour, Amina BadrEldin, Maryam Rahman, Lobna R. Ezz El Arab, Nermeen N. Aziz · 2023 · The Egyptian Rheumatologist
  10. Application of Nano-Delivery System in Tumor Immunotherapy
    豪华 袁 · 2023 · Hans Journal of Nanotechnology
  11. Autoimmune Phenomena in Cancer Patients Treated with Immune Checkpoint Inhibitors
    Milena Tocut, Michael Ehrenfeld, Gisele Zandman‐Goddard · 2024
  12. Neurologically relevant immune-related adverse events associated with immunotherapy for lung cancer in clinical trials: a systematic review and meta-analysis
    Yanli Yang, Ruo‐Lan Xiang, Siyuan Fan, Yan Kang Xu, Wei Zhong, Mengzhao Wang · 2026 · European journal of medical research
  13. Notfälle in der Medikamentösen Tumortherapie
    Analena Elisa Handke, Thomas Hilser, Martin Bögemann, Katrin Schlack, Viktor Grünwald · 2024 · Onkologische Welt
  14. Neuropsychological issues related to immunotherapy
    Gilbert Youssef, Eudocia Q. Lee · 2024 · Elsevier eBooks
  15. The Role of Cd26 in Breast Cancer and its Pan-Cancer Analysis
    Runyi Tao, Liu Bohao, Shan Gao, Jizhao Wang, Qiuyu Gong, Yanpeng Zhang, Peng Li, Xingzhuo Zhu, Yilong Zhao, Jiaqi Huang et al. · 2024 · SSRN Electronic Journal
  16. Notfälle in der Medikamentösen Tumortherapie
    Analena Elisa Handke, Thomas Hilser, Martin Bögemann, Katrin Schlack, Viktor Grünwald · 2024 · TumorDiagnostik & Therapie
  17. Neoadjuvant Immunotherapy as a risk factor for hashimoto’s disease
    Amália Cínthia Meneses do Rêgo, Irami Araújo-Filho · 2024 · Endocrinology&Metabolism International Journal
  18. Nephrological and Rheumatic Complications of Checkpoint Inhibitors
    Roberta Fenoglio, Dario Roccatello, Antonella Barreca, Emanuele De Simone, Savino Sciascia · 2024 · Rare diseases of the immune system
  19. Neurological Complications of Immune Check Point Inhibitors
    Sri Raghav Sista, Naveen Kumar Paramasivan, Divyanshu Dubey · 2024 · Elsevier eBooks
  20. Immune-checkpoint Inhibitors in Anti-cancer Armamentarium: a Double-edged Sword in Risk of Developing Autoimmunity and Immune-related Adverse Effects
    2025 · Frontiers research topics
  21. (Invited) Brief Review: Progress of Tumor Active Targeting Bionic Nano-delivery System for Improving Tumor Immunotherapy Research
    Yao Wang, Ping Zhong, Weidong Li, Na Song · 2025 · Nano LIFE
  22. mRNA cancer vaccines: features of problems and collisions
    E. P. Kharchenko · 2025 · Molecular Genetics Microbiology and Virology (Russian)
  23. A Case of Seronegative Myopathy-Myocardial Injury Due to PD-1 Inhibitor and Literature Review
    新源 苗 · 2025 · Advances in Clinical Medicine
  24. Large vessel vasculitis associated with atezolizumab
    Prathyusha Chennupati, Erika Pianin, Neil Kramer, Elliot D. Rosenstein · 2025 · BMJ Case Reports
  25. Case Report: Laser speckle flowgraphy in a patient with uveitis due to immune-related adverse events by immune checkpoint inhibitors
    Satoru Kase, Yui Yamashita, Satoshi Takeuchi, Susumu Ishida · 2025 · Frontiers in Oncology
  26. mRNA Cancer Vaccines: Features of Problems and Collisions
    E. P. Kharchenko · 2025 · Molecular Genetics Microbiology and Virology
  27. Code to cure: computational genomics and proteomics in biomedical research and therapeutics
    Taru Singh, Sameer Singh, Uzma Iftekhar, Aleena Taufiq · 2025 · Elsevier eBooks
  28. Eva Klein, a tumorimmunológia anyja (1925–2025)
    Tibor Bakács · 2025 · Magyar Tudomány
  29. Clinical Applications of Novel Delivery Routes of Immunotherapy Drugs and Vaccines
    Simin Seyedpour, Nima Rezaei · 2025 · Springer eBooks
  30. Turning self cancer cells into nonself by viral xenogenization to ignite response in immune checkpoint inhibitors nonresponders
    Tibor Bakács · 2025 · Elsevier eBooks
  31. Combination of infectious bursal disease virus with ultra-low doses of nivolumab plus ipilimumab could provide functional cure in chronic hepatitis B virus infections
    Tibor Bakács, Imre Kovesdi, Rifaat Safadi · 2025 · Elsevier eBooks
  32. Additional file 1 of Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia
    Mishra, Radhika, Ariunbuyan Sukhbaatar, Shiro Mori, Kodama, Tetsuya · 2023 · Figshare
  33. Additional file 2 of Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
    Yun Hu, Paris, Sébastien, Genevieve Bertolet, Hampartsoum B. Barsoumian, He, Kewen, Sezen, Duygu, Chen, Dawei, Mark D. Wasley, SILVA, Jordan DA, Joylise Mitchell et al. · 2022 · Figshare
  34. Additional file 1 of Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
    Yun Hu, Paris, Sébastien, Genevieve Bertolet, Hampartsoum B. Barsoumian, He, Kewen, Sezen, Duygu, Chen, Dawei, Mark D. Wasley, SILVA, Jordan DA, Joylise Mitchell et al. · 2022 · Figshare
  35. Le lien entre auto-immunité et immunosurveillance des cancers dans le cas des cholangites et du cholangiocarcinome
    Juliette Paillet · 2020 · theses.fr (ABES)
  36. Ultrasons thérapeutiques pour application en oncologie : optimisation de thérapies thermique et mécanique avec un système confocal pour des traitements combinés, et développement de nanoparticules pour une activation immunitaire
    Myléva Dahan · 2023
  37. Défaut de tolérance des lymphocytes B et sa restauration dans les maladies auto-immunes
    Adrien Mirouse · 2024
  38. Immune-mediated Arthritis after Treatment with Nivolumab in a Patient with Malignant Melanoma
    Ivelina Ivanova · 2026 · Rheumatology (Bulgaria)
  39. Rapid exacerbation of bilateral hip osteoarthritis induced by immune checkpoint inhibitor therapy: A case report
    Yuta Imamura, Yuya Takakubo, Hanqing Huang, Juji Ito, Masashi Aso, Yoshihiro Wanezaki, Tomohiro Uno, Yasushi Naganuma, Suran Yang, Hiroharu Oki et al. · 2026 · Modern Rheumatology Case Reports
  40. Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases
    Junho Kang, Jinhyeon An, Jung Kyoon Choi · 2026 · Journal for ImmunoTherapy of Cancer
  41. Utilizing nanomedicines to modulate myeloid-derived suppressor cells: Enhancing cancer immunotherapy
    Smita Kumbhar, Manish S. Bhatia · 2026 · Elsevier eBooks
  42. Immune checkpoint inhibitor-associated eosinophilic fasciitis: a systematic review of reported cases
    Yahya Argobi, Faisal Hassan Tobeigei, Faris I. Alasiri · 2026 · Anais Brasileiros de Dermatologia
  43. Cancer Immunotherapy and Toxicity: Biomarkers, Mechanisms and Translational Insights
    Zoltán Lohinai, Arghajit Biswas · 2026 · IntechOpen eBooks
  44. PD-L1 expression in germinal centers promotes humoral immunity by restricting T follicular regulatory cell differentiation
    Elliot H. Akama‐Garren, Yingying Zhang, Balthasar A. Heesters, Padraic G. Fallon, Michael C. Carroll · 2026 · Immunity
  45. Immune checkpoint inhibitor-induced diabetes mellitus: A review of mechanisms, clinical features, and therapeutic approaches
    Mohammad Parsapour, Pouya Mahdavi Sharif, Nima Rezaei · 2026 · Pathology - Research and Practice